Achieve new breakthroughs in RNA
RNA Therapeutics R&D Solutions
Benchling’s RNA Therapeutics Solution was developed in partnership with leading industry innovators. For the first time, R&D teams can design natural and chemically modified oligonucleotides, mRNA, and other RNA sequences in a single solution. They can also centralize experimental results, standardize on syntax, and collaborate with teammates more effectively on a single platform. Our modern, digital R&D solution combines the capabilities expected from in silico design tools, ELN, and LIMS into one modern, unified, fully-configurable, and easy-to-use solution that adapts to the rapidly evolving needs of RNA therapeutics R&D.
The RNA Therapeutics R&D Accelerators provide best practices that shorten time-to-value for research and process development. The Accelerators contain:
Data model – entity relationship diagram (ERD) which serves as an implementation blueprint
Tenant configuration – pre-defined tenant configuration using templates and dashboards for registering entities, tracking results, increasing inventory utilization, and streamlining workflows
Solution Guide – highlight capabilities and latest product features
Benchling’s services support customers from implementation through ongoing success.
How we deliver
Our Customer Experience professionals possess deep scientific expertise as well as training on information technology best practices. They apply this know-how to support RNA therapeutic customers across a wide range of R&D teams.
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Focused R&D support
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many RNA Therapeutic R&D functions.